Early Prediction of Response to First-Line Therapy Using Integrated 18F-FDG PET/CT for Patients with Advanced/Metastatic Non-small Cell Lung Cancer

Single 18-fluorodeoxyglucose positron emission tomography/computed tomography scan taken after one cycle of treatment could predict progressive disease earlier than standard radiographic evaluation and can be used as a measure to avoid ineffective systemic chemotherapy.